Web Analytics
TNGX (NASDAQ) 株価分析 | TANGO THERAPEUTICS INC – Deepscope
MARKET

Select Market Data Region

TNGX 株価分析 — TANGO THERAPEUTICS INC (Healthcare >> Biotechnology)

TNGX に関するよくある質問

TNGXのPER(株価収益率)は?

TANGO THERAPEUTICS INC(TNGX)は現在PER 282.60倍で取引されています。

TNGXのROE(自己資本利益率)は?

TANGO THERAPEUTICS INCのROEは-27.39%です。

TNGXの配当利回りは?

TANGO THERAPEUTICS INCの配当利回りは0.00%です。

TNGXの品質スコア(Quality Score)は?

当社のAIはTNGXの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

TNGXは今が買い時ですか?

当社AIのタイミングスコアは100点中67点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

TNGXはどのセクターに属しますか?

TANGO THERAPEUTICS INCはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-07-31 | FS: 2026-03-31)

TNGX AI Analysis Summary

Our AI summary for TNGX: TANGO THERAPEUTICS INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 282.60, ROE of -27.39%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

TNGX

TANGO THERAPEUTICS INC
USD 27.18
-0.39 (-1.41%) Day Change
282.60
P/E
0.01
D/E
-27.4%
ROE
-24.6%
ROA
0.00%
Div Yield
-29.78
PEG
USD 27.18
Price
-0.39 (-1.41%)
Day Change
NEWS SCORE: 81

TNGX, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析 42%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 81
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 27.18
  PBV / Sector
11.47 / 5.20
  Earning Per Share -0.65
  PE / Sector
282.60 / 19.97
  PEG or PE/Growth / Sector
-29.78 / 1.22
  Average 1M Daily Value
64.59 M
  Average 1W Daily Value
49.67 M
GREAT
Timing Factors 28%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ポイントになる統計 52%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-188.15 / 98.71
  NPM Average (%) / Sector
-274.89 / -1,721.76
  NPM Change Average (%) / Sector
-14.17 / 5,211.62
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-24.61 / 27.02
  ROA Average (%) / Sector
-28.26 / -368.17
  ROA Change Average (%) / Sector
5.83 / 5,404.12
  ROE (%) / Sector
-27.39 / 3.47
  ROE Average (%) / Sector
-41.12 / 6.51
  ROE Change Average (%) / Sector
-1.64 / 2,128.13
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
配当 4%
X
  Dividend (%) / Sector
N/A / 0.04
  Dividend Average (%) / Sector
N/A / 17.04
  Dividend Change Average (%) / Sector
N/A / -1.75
登録情報
X
  Analyze Date 2026-08-01 08:00:35
  Symbol TNGX
  Name TANGO THERAPEUTICS INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 162.81 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 4,488.80 / 9,903.94
ニュース
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 201 Brookline Avenue, Boston, MA, United States, 02215

Phone: 857 320 4900

Website: https://www.tangotx.com

Employees: 137

Sector: Healthcare >> Biotechnology

Description: Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Analyst Ratings & Target Price

3 Months Ago
1 Month Ago
Current
Strong Buy
6
6
6
Buy
2
2
2
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
Consensus
Strong Buy 4.75
Strong Buy 4.75
Strong Buy 4.75
Target Price
USD 23.90
USD 43.82
USD 44.33

Per-Share Earnings, Estimates vs Actuals

Actual
Analyst Range
Estimate

ME vs SECTOR Healthcare >> Biotechnology

TNGX (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

同業種の銘柄

Healthcare › Biotechnology

同じ基準で分析・時価総額順

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
TNGX
TNGX
USD 27.18 (-1.41%)
+ Watch + Port Chart